The Patent Finder

Fas Secured Creditors Holdco, LLC

Also on record
Records under this name other than the patents Fas Secured Creditors Holdco, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Fas Secured Creditors Holdco, LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,649,012Pharmaceutical Compositions Containing Same, and Methods of Use for Same
Lapsed on the fee record
Ended Jan 19, 2018 · High confidence
Lapsed on the fee recordEnded Jan 19, 2018High confidence
US 7,459,481Stimulation of CPT-1 as a Means to Reduce Weight
Lapsed on the fee record
Ended Dec 2, 2016 · High confidence
Lapsed on the fee recordEnded Dec 2, 2016High confidence
US 8,293,791Novel Method of Neuroprotection by Pharmacological Inhibition of Amp-Activated Protein Kinase
Lapsed on the fee record
Ended Oct 23, 2016 · High confidence
Lapsed on the fee recordEnded Oct 23, 2016High confidence
US 8,247,188FAS binding antibodies
Lapsed on the fee record
Ended Aug 21, 2016 · USPTO record
Lapsed on the fee recordEnded Aug 21, 2016USPTO record
US 7,385,086Antimicrobial Compounds
Lapsed on the fee record
Ended Jun 10, 2012 · Medium confidence
Lapsed on the fee recordEnded Jun 10, 2012Medium confidence
US 6,713,654Antimicrobial compounds
Lapsed on the fee record
Ended Mar 30, 2012 · USPTO record
Lapsed on the fee recordEnded Mar 30, 2012USPTO record
US 5,614,551Inhibitors of fatty acid synthesis as antimicrobial agents
Term ended
Term ended no later than Mar 25, 2017 · Low confidence
Term endedTerm ended no later than Mar 25, 2017Low confidence
US 5,665,874Cancer related antigen
Term ended
Term ended no later than Sep 9, 2017 · Low confidence
Term endedTerm ended no later than Sep 9, 2017Low confidence
US 5,759,791Cancer related antigen
Term ended
Term ended no later than Jun 2, 2018 · Low confidence
Term endedTerm ended no later than Jun 2, 2018Low confidence
US 5,759,837Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
Term ended
Term ended no later than Jun 2, 2018 · Low confidence
Term endedTerm ended no later than Jun 2, 2018Low confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited